- In mid-2025, the Trump administration and HHS Secretary Robert F. Kennedy Jr. moved to reshape federal public health via leadership shakeups, staffing cuts, and major agency reorganizations.
- Kennedy dismissed all 17 members of the CDC’s vaccine advisory committee (ACIP) and quickly appointed replacements, raising concerns about independence and scientific rigor.
- The proposed FY 2026 budget would cut CDC/ATSDR by about 50% and NIH by about 40%, eliminating scores of prevention and preparedness programs.
- Critics warn these changes could weaken surveillance, immunization policy, emergency readiness, and public trust as health threats persist.
Read More
Analysis of Key Developments & Strategic Implications
1. Advisory Panels and Scientific Oversight
In June 2025, HHS Secretary Robert F. Kennedy Jr. removed all 17 members of the Advisory Committee on Immunization Practices (ACIP), replacing them with new members, some with ties to vaccine skepticism or misinformation. The administration justified this move citing conflicts of interest, though independent reviews and fact-checkers found those claims to be largely unsubstantiated. Critics warn this dismantles institutional continuity and could reduce rigor in vaccine policy decisions.
2. Staffing, Structure, and Budgetary Realignments
The proposed FY 2026 budget seeks to cut the CDC/ATSDR funding by over 50% compared to FY 2024 and NIH by approximately 40%. Concurrently, the reorganization of HHS aims to reduce its overall workforce by about 16-20%, including major cuts at FDA and CDC. Some roles have been reinstated amidst backlash, but the scale of down‐sizing is large. Such changes are likely to impair capacity for routine public health functions.
3. Program Eliminations and Priority Shifts
A report from Trust for America’s Health catalogues over 100 public health programs at risk under the proposed FY 2026 budget: cancer, diabetes, HIV/AIDS prevention, obesity, global immunization, and others. Cuts extend to emergency preparedness—CDC’s Public Health Emergency Preparedness program faces over 50% proposed reduction. These moves signal a shift in priorities that may leave the U.S. less prepared for outbreaks or chronic disease burdens.
4. Trust, Communication, and Long-Term Risk
The administration asserts that changes—in panels, budgets, and advisory structures—are intended to “restore public trust.” Yet independent groups argue that abrupt dismissals of long-serving experts, lack of transparency, and policy reversals may instead erode trust further. Epidemiologists, vaccine experts, and public health institutions warn that inconsistent messaging and advisor turnover will degrade vaccine uptake and surveillance.
Open Questions
- Will new ACIP appointees maintain scientific standards broadly accepted by the public health community, and how quickly will they gain institutional credibility?
- Can key programs—like emergency preparedness, immunization, and global health initiatives—survive the proposed cuts without compromising outcomes?
- How will states and local health departments fill gaps if federal support wanes, given their historically uneven capacities?
- What will be the long-term impacts on public health workforce morale, retention, and capability under large layoffs and restructuring?
Supporting Notes
- Kennedy removed all 17 ACIP members in June 2025, citing alleged conflicts of interest and claims the panel was a “rubber stamp” for vaccines. Experts dispute those claims, citing minimal or no recent conflicts and strong prior performance by the panel.
- A few days after the dismissals, 8 new members were appointed; among them are individuals with histories of vaccine skepticism, a critic of COVID lockdowns, and a person involved with groups associated with vaccine misinformation.
- The proposed FY 2026 budget cuts CDC/ATSDR funding by ~53% relative to FY 2024 and NIH by ~40%; over 100 public health programs face elimination, including major prevention and disease control initiatives.
- HHS reorganization plan includes reducing the total number of full-time employees from 82,000 to about 62,000—roughly 20,000 staff reductions—especially at FDA and CDC (~20% cuts each) in non-review and inspector roles.
- Kennedy has rehired some staff (722 at CDC, 220 at NIH) after recognizing that key positions were needed to maintain certain functions despite broader cuts.
- Public health advocacy groups warn that the budget proposal could leave the U.S. unprepared for future pandemics and reduce its ability to innovate, regulate, and respond to health threats.